Created at 12:44 a.m. May, 28, 2025
Author: gnigam
Related Note: 1485042663916 3
Rationale for change

Likewise, specifying here
Source: AMBOSS - https://next.amboss.com/us/article/_N05dg?utm_source=navbar&utm_medium=anki&utm_campaign=anki&utm_term=tricyclic%2Bantidepressants&guid=v7tG8NJS%253D~&aid=b566793c-3b1e-47e9-9c87-0f96072b21c8&uid=icxeJXvaa#Z1ac38cdc312662760e7dcb2548983f5b

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#UWorld::COMLEX::23687 #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step1_v12::#NinjaNerd::04_Pharmacology::01_Basics::05_Antiarrhythmic_Drugs #AK_Step1_v12::#FirstAid::13_Psych::02_Pathology::40_Psychiatric_emergencies::*Tricyclic_Antidepressant_Overdose::Pathophysiology #AK_Step2_v12::#NBME #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::06_Tricyclic_Antidepressants_(TCAs) #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step1_v12::#Bootcamp::Pharmacology::04_Side_Effects_and_Toxins::02_Pharmacological_Toxicity_and_Treatment #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::21_Tricyclic_Antidepressants #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Other::!AK_UpdateTags::AnKing_Image::AhmedK::QT_Interval_Prolongation #PANCE::BEHAVIORAL::depression #AK_Step1_v12::#UWorld::Step::574 #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::03_Tricyclic_Antidepressants #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#B&B::19_Psych::04_Pharm::01_Antidepressants::Extra #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Cardiology::QT_Interval_Prolongation #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#AMBOSS::_R05pf #AK_Step2_v12::#AMBOSS::-taDTm #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::04_Drug_reactions-cardiovascular #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Cardiology::15_Ventricular_Arrhythmias::03_Torsades_de_Pointes #AK_Step1_v12::#AMBOSS::#Self_Assessment #AK_Step1_v12::#Bootcamp::Cardiology::12_Cardiac_Conductive_Physiology::04_Variables_of_Cardiac_Potentials #AK_Step2_v12::#SketchyIM::02_ECG_Interpretation_&_Arrhythmias::05_Retired_Lessons::02_ECG_Interpretation::01_ECG_Interpretation_[OLD_VERSION] #PANCE::EOR::PSYCH #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::02_Antidepressants_&_Anxiolytics::02_Tricyclic_Antidepressants #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::01_Antidepressants #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::09_Tricyclic_antidepressants